Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Open Access Journal of Pharmaceutical Research Research Article 2 min read

No to the Herd Immunity against Novel Coronavirus (SARSCov-2) without Vaccination

Mahmood MM*
* Corresponding author
ISSN: 2574-7797  10.23880/oajpr-16000204  Received: June 01, 2020  Published: June 08, 2020
  views
PDF
Abstract

The sheer importance of the herd’s immunity in protecting societies from the burden of contagious diseases and in providing opportunities for survival and continuity has not hidden after those societies were threatened, even with the disappearance sometimes by some infectious factors. Herd immunity can be achieved either through vaccination of large sectors of society, or it may sometimes be achieved by infection of a large proportion of society members naturally and acquiring natural immunity after recovery, or by both ways.

Opinion

The sheer importance of the herd’s immunity in protecting societies from the burden of contagious diseases and in providing opportunities for survival and continuity has not hidden after those societies were threatened, even with the disappearance sometimes by some infectious factors. Herd immunity can be achieved either through vaccination of large sectors of society, or it may sometimes be achieved by infection of a large proportion of society members naturally and acquiring natural immunity after recovery, or by both ways.

But there is a worrying issue if hopes were built in the case of the COVID-19 pandemic to reach the herd immunity by letting societies acquire natural immunity through infection, although this seems to be encouraging in theory, especially since most individuals who are immunocompetent are not very afraid of the complications of infection.

As the real potential danger lies in the fact that this renewed virus if it were allowed to infect members of society openly, will have tremendous opportunities to multiply and produce unlimited copies of it, and the accompanying Opinion mutations and mutations (taking into account the issue of mutation rate) which may include mutations that give the virus new characteristics that enable it to acquire New pathological characteristics of which consequences are not in the count.

This would transfer the virus from its current form to a deadly form or forms that humanity may not bear its burden and may not be within the spectrum of the human immune system’s capabilities to deal with it and the list of possibilities remains open to what its boundaries are unknown. The more numbers of multiplication of the virus and the production of new copies, the more random mutations and with it the possibility of creating copies of the virus with suspicious pathological specifications, or the opposite maybe, that is, producing benign copies that give us positive opportunities to coexist with the virus.

However, logic requires us to take the first possibility to avoid the possibility of the emergence of highly harmful copies of the virus, and that we tend to achieve the herd immunity primarily through vaccination.

Cite this article

BibTeX
APA
RIS
@article{mahmood2020,
  title   = {No to the Herd Immunity against Novel Coronavirus (SARSCov-2) without Vaccination},
  author  = {Mahmood MM},
  journal = {Open Access Journal of Pharmaceutical Research},
  year    = {2020},
  volume  = {4},
  number  = {2},
  doi     = {10.23880/oajpr-16000204}
}
Mahmood MM (2020). No to the Herd Immunity against Novel Coronavirus (SARSCov-2) without Vaccination. Open Access Journal of Pharmaceutical Research, 4(2). https://doi.org/10.23880/oajpr-16000204
TY  - JOUR
TI  - No to the Herd Immunity against Novel Coronavirus (SARSCov-2) without Vaccination
AU  - Mahmood MM
JO  - Open Access Journal of Pharmaceutical Research
PY  - 2020
VL  - 4
IS  - 2
DO  - 10.23880/oajpr-16000204
ER  -